Our most recent addition, Owen came on board in the spring of 2022. He started his career on Wall Street over 20 years ago at a long/short hedge fund, where he was the specialty pharmaceutical and medical device equity analyst as well head trader. After leaving the fund in 2008, in the aftermath of the financial crisis, he went on a veritable tour of Wall Street, trading all manner of stocks, bonds, and derivatives on the institutional side of the business. Immediately prior to Willow Creek, he was the Controller at Dianomi Therapeutics, a venture capital backed biotechnology company.
When he’s not in the office tracking market movements and parsing economic data, you can find him floating the Blackfoot with his wife and two dogs or chasing powder stashes at Snowbowl.
Raymond James is not affiliated with the above organizations and/or charitable causes.